Publications

Cell reports. Medicine

RadioLOGIC, a healthcare model for processing electronic health records and decision-making in breast disease.

15-08-2023

Cellular and molecular life sciences : CMLS

Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells.

14-08-2023

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to G. Wang et al.

14-08-2023

The Journal of clinical investigation

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.

10-08-2023

Breast cancer research : BCR

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

09-08-2023

Pigment cell & melanoma research

Seasonal variation of anti-PD-1 outcome in melanoma-Results from a Dutch patient cohort.

08-08-2023

Cancer discovery

Dual immune checkpoint blockade induces analogous alterations in the dysfunctional CD8+ T cell and activated Treg compartment.

07-08-2023

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Sense and nonsense of yT-staging on MRI after chemoradiotherapy in rectal cancer.

06-08-2023

Journal of proteome research

Determining DNA-Protein Binding Affinities and Specificities from Crude Lysates Using a Combined SILAC/TMT Labeling Strategy.

04-08-2023

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Inhibiting the Glucocorticoid Receptor to Enhance Chemotherapy Response.

03-08-2023

Molecular cell

Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens.

03-08-2023

BJU international

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.

01-08-2023

CPT: pharmacometrics & systems pharmacology

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of ¹⁷⁷ Lu-PSMA-617 in prostate cancer patients.

01-08-2023

Journal of cancer survivorship : research and practice

Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

01-08-2023

Pharmaceutical research

P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice.

01-08-2023

European urology open science

State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic Review.

01-08-2023

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.

01-08-2023

Clinical and translational medicine

MIND the translational gap: Preclinical models of ductal carcinoma in situ.

01-08-2023

The Journal of pathology

Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.

01-08-2023

Cancer research communications

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model.

01-08-2023

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

In Response to Arcidiacono et al.: "Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?".

01-08-2023

Nature

cGAS-STING drives ageing-related inflammation and neurodegeneration.

01-08-2023

The Journal of pathology

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

01-08-2023

The Journal of pathology

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.

01-08-2023

Drug discovery today

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

01-08-2023

Clinical pharmacokinetics

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

01-08-2023

ESMO open

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors.

01-08-2023

European journal of cancer (Oxford, England : 1990)

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

01-08-2023

JAMA network open

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer.

01-08-2023

The Lancet. Oncology

Common Sense Oncology: outcomes that matter.

01-08-2023

Breast (Edinburgh, Scotland)

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.

01-08-2023

Virchows Archiv : an international journal of pathology

Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging.

01-08-2023

Annals of surgical oncology

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

01-08-2023

Clinical pharmacokinetics

Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.

01-08-2023

Cancer medicine

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

01-08-2023

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.

01-08-2023

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development.

01-08-2023

Die Pharmazie

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

01-08-2023

Patient education and counseling

Effects of a pre-visit online information tool about genetic counselling for ovarian cancer patients, a randomized controlled trial.

01-08-2023

Journal of cancer research and clinical oncology

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

31-07-2023

Journal of gastroenterology

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer.

31-07-2023

Acta oncologica (Stockholm, Sweden)

Involving adolescents and young adults (AYA) with an uncertain or poor cancer prognosis as research partners.

28-07-2023

International journal of radiation oncology, biology, physics

Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

28-07-2023

Investigative radiology

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction.

27-07-2023

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

24-07-2023

Nature communications

Obesity-associated changes in molecular biology of primary breast cancer.

21-07-2023

Insights into imaging

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.

21-07-2023

Journal of patient-reported outcomes

Monitoring aerobic capacity in cancer survivors using self-reported questionnaires: criterion validity and responsiveness.

19-07-2023

Nature medicine

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

17-07-2023

International journal of cancer

Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.

15-07-2023

RadioLOGIC, a healthcare model for processing electronic health records and decision-making in breast disease.

Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells.

Reply to G. Wang et al.

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

Seasonal variation of anti-PD-1 outcome in melanoma-Results from a Dutch patient cohort.

Dual immune checkpoint blockade induces analogous alterations in the dysfunctional CD8+ T cell and activated Treg compartment.

Sense and nonsense of yT-staging on MRI after chemoradiotherapy in rectal cancer.

Determining DNA-Protein Binding Affinities and Specificities from Crude Lysates Using a Combined SILAC/TMT Labeling Strategy.

Inhibiting the Glucocorticoid Receptor to Enhance Chemotherapy Response.

Genome-scale mapping of DNA damage suppressors through phenotypic CRISPR-Cas9 screens.

Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177 Lu-PSMA-617 in prostate cancer patients.

Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice.

State of the Art in Prostate-specific Membrane Antigen-targeted Surgery-A Systematic Review.

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.

MIND the translational gap: Preclinical models of ductal carcinoma in situ.

Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model.

In Response to Arcidiacono et al.: "Should dose intensification be discontinued or should accelerated schemes remain an important area of clinical research?".

cGAS-STING drives ageing-related inflammation and neurodegeneration.

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors.

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer.

Common Sense Oncology: outcomes that matter.

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial.

Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging.

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.

Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development.

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

Effects of a pre-visit online information tool about genetic counselling for ovarian cancer patients, a randomized controlled trial.

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer.

Involving adolescents and young adults (AYA) with an uncertain or poor cancer prognosis as research partners.

Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction.

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

Obesity-associated changes in molecular biology of primary breast cancer.

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.

Monitoring aerobic capacity in cancer survivors using self-reported questionnaires: criterion validity and responsiveness.

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.

This site uses cookies

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of ¹⁷⁷ Lu-PSMA-617 in prostate cancer patients.